Lecture 18 - Chronic Kidney Disease Flashcards
Is Acute or Chronic kidney disease associated with Oliguria?
Acute is. Chronic may even result in Polyuria, especially at night.
CKD stages (from most severe to least):
Stage 5 = GFR < _____.
Stage 4 = GFR ___ - ___
Stage 3 = GFR ___ - ___
Stage 2 = GFR ___ - ___
Stage 1 = GFR > ___.
What must also be present for Stage 1 and 2 classification?
Stage 5 = GFR < 15.
Stage 4 = GFR 15 - 29
Stage 3 = GFR 30 - 59
Stage 2 = GFR 60 - 89
Stage 1 = GFR > 89
Must also have kidney damage for stage 1 and 2.
Both GFR and _____ clearance are important factors for determining Prognosis of CKD.
Albumin
African Americans have a higher incidence of mutation in ______, which is a predisposing factor for non-diabetic CKD AND more rapid decline in GFR.
APO-L1
Controlling _____ is considered to be the most important factor for controlling CKD. What is the target value for this in Proteinurics and Diabetics?
BP
< 130/80
Do not ever combine an ACE inhibitor with what?
ARB (Angiotensin Receptor Blocker)
Angioedem and hyper______ are the main CONTRAindications for administration of ACE inhibitors and/or ARBs.
Hyperkalemia
What is the biggest comorbid factor and cause of death in CKD patients?
Cardiovascular events
Generally speaking, patients of CKD Stage 4 or below should be treated with _____ to help lower lipids and decrease risk of cardiovascular events.
Statins
Patients with serum HCO3- < _____ should be treated with supplemental HCO3- (typically Na+HCO3-) to avoid Hyperkalemia. Keep in mind the target is to get serum HCO3- above that mark.
< 20
Treating Hyperkalemic patients with low K+ diet is the gold standard. However, medications that bind K+ in the gut to reduce it in serum include SGS, ______, and Sodium Zirconium Cyclosilicate.
SGS, Patiromer, and Sodium Zirconium Cyclosilicate
CKD patients with high levels of serum Phosphate have WORSE outcomes. Is inorganic or organic phosphate more readily absorbed from the diet?
Inorganic (very highly present in Colas).
Target Phosphate level for ESRD patients is < ____. For non-ESRD CKD patients < ____.
Target Ca++ in CKD of all stages is < _____.
ESRD: < 5.5
Non-ESRD CKD: < 4.5
Ca++ target < 9.5
Treatment of CKD patients with which Vit improves outcomes?
1,25 dihydroxy D3
Anemia in CKD patients can be caused by absolute deficiency or functional deficiency. In either case, the actions of which molecule are the root cause?
Hepcidin –> in Absolute deficiency it decreases Fe++ absorption in gut; In Functional deficiency it causes Fe++ sequestration from inflammation.